Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer

Fig. 5

Establishment and characterization of colorectal cancer organoids. A Light microscopic (left column) and HE staining of four lines of organoids (middle column) and the corresponding tumor tissue (right column). HE, Hematoxylin–eosin staining; BF, Bright field. Scale bar 100 μm. B Non-synonymous mutated genes detected in CRC-1 and paired tumor tissue (CRC-1-Tumor). MultiHits indicates multiple mutations occur in the gene

Back to article page